Industry
Sponsored by
A new method published in June 2024 represents a significant leap forward in the quality control of probiotic products.
Microbiomepost conducted an exclusive interview with Nuria Vieco, Adisseo France S.A.S, European Laboratory of Innovation Science and Expertise ELISE, about the effect of Bacillus subtilis DSM29784 secreted metabolites on poultry…
The findings of a recent study suggest that combining dietary fiber with B. acidifaciens can be a therapeutic strategy for alcoholic liver disease.
The findings suggest that artificial intelligence can help uncover new antibiotics, opening the way for new approaches to antibiotic discovery. The work also offers an open-access resource for antibiotic developers.
This funding aims to propel the development of bacterial products and therapies that are not only unique but immune to viruses, enhancing their therapeutic potential.
Microbiomepost conducted an exclusive interview with Jiri Snaidr, Founder and CEO at Vermicon AG, about the possibility to combine Fluorescence In Situ Hybridization (FISH) and Digital PCR (dPCR) for advanced…
The findings of a recent study may inform the development of antibiotics that kill harmful bacteria and not beneficial ones.
The findings of a recent study suggest that the gut microbiota of women with PCOS and dyslipidemia differs from that of women with PCOS only and healthy women.
An innovative tool for higher yields and greater efficiency
Microbiomepost conducted an exclusive interview with Eric Daliri, from Vilnius University, about the possibility of prevent diabetes modulating gut microbiome.
